共 50 条
- [1] Intratumor heterogeneity of EGFR expression mediates targeted therapy resistance and formation of drug tolerant microenvironmentNATURE COMMUNICATIONS, 2025, 16 (01)Alsaed, BasselLin, LinhSon, JieunLi, JiaqiSmolander, JohannesLopez, TimothyEser, Pinar O.Ogino, AtsukoAmbrogio, ChiaraEum, YoonjiThai, TranWang, HaiyunSutinen, EvaMutanen, HilmaDuan, HannaBobik, NinaBorenius, KristianFeng, William W.Nabet, BehnamMustjoki, SatuLaaksonen, SannaEschle, Benjamin K.Poitras, Michael J.Barbie, DavidIlonen, IlkkaGokhale, PrafullaJanne, Pasi A.Haikala, Heidi M.
- [2] Shades of T790M: Intratumor Heterogeneity in EGFR-Mutant Lung CancerCANCER DISCOVERY, 2015, 5 (07) : 694 - 696Ichihara, EikiLovly, Christine M.
- [3] Overcoming therapy resistance in EGFR-mutant lung cancerNature Cancer, 2021, 2 : 377 - 391Antonio PassaroPasi A. JänneTony MokSolange Peters
- [4] Overcoming therapy resistance in EGFR-mutant lung cancerNATURE CANCER, 2021, 2 (04) : 377 - 391Passaro, AntonioJanne, Pasi A.Mok, TonyPeters, Solange
- [5] Optimizing the Sequence of Anti-EGFR-Targeted Therapy in EGFR-Mutant Lung CancerMOLECULAR CANCER THERAPEUTICS, 2015, 14 (02) : 542 - 552Meador, Catherine B.Jin, Hailingde Stanchina, ElisaNebhan, Caroline A.Pirazzoli, ValentinaWang, LuLu, PengchengVuong, HuyHutchinson, Katherine E.Jia, PeilinChen, XiEisenberg, RosanaLadanyi, MarcPoliti, KaterinaZhao, ZhongmingLovly, Christine M.Cross, Darren A. E.Pao, William
- [6] Resistance to Afatinib and Cetuximab Combination Therapy in EGFR-mutant Lung AdenocarcinomasCLINICAL CANCER RESEARCH, 2012, 18 (10)Pirazzoli, ValentinaTakezawa, Kende Stanchina, ElisaPao, WilliamPoliti, Katerina
- [7] Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancerJOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (02):Wang, ShidanRong, RuichenYang, Donghan M.Fujimoto, JunyaBishop, Justin A.Yan, ShirleyCai, LingBehrens, CarmenBerry, Lynne D.Wilhelm, ClareAisner, DaraSholl, LynetteJohnson, Bruce E.Kwiatkowski, David J.Wistuba, Ignacio I.Bunn, Paul A.Minna, JohnXiao, GuanghuKris, Mark G.Xie, Yang
- [8] Deep learning radiopathomics predicts targeted therapy sensitivity in EGFR-mutant lung adenocarcinomaJournal of Translational Medicine, 23 (1)Taotao YangXianqi WangYuan JinXiaohong YaoZhiyuan SunPinzhen ChenSuyi ZhouWentao ZhuWei Chen
- [9] TARGETED THERAPIES Afatinib-new therapy option for EGFR-mutant lung cancerNATURE REVIEWS CLINICAL ONCOLOGY, 2013, 10 (10) : 551 - 552Yu, Helena A.Pao, William
- [10] Clonal dynamics of BRAF-driven drug resistance in EGFR-mutant lung cancernpj Precision Oncology, 5Diana SchauflerDavid F. AstHannah L. TumbrinkNima AbedpourLukas MaasAyla E. SchwäbeInga SpilleStefanie LennartzJana FassunkeMihaela AldeaBenjamin BesseDavid PlanchardLucia NogovaSebastian MichelsCarsten KobeThorsten PersigehlTheresa WestphalSophia KoleczkoRieke FischerJan-Phillip WeberJanine AltmüllerRoman K. ThomasSabine Merkelbach-BruseOliver GautschiLaura MezquitaReinhard BüttnerJürgen WolfMartin PeiferJohannes BrägelmannMatthias SchefflerMartin L. Sos